Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Single-Photon Emission Computed Tomography Market Outlook (2022 to 2032)

The global single-photon emission computed tomography market size reached US$ 2.28 Billion in 2021 and it is expected to enjoy a valuation of US$ 2.45 Billion by the end of 2022. Furthermore, with the rising prevalence of various cardiovascular diseases and the growing need for better diagnostic technologies, the overall demand for single-photon emission computed tomography (SPECT) is poised to grow at 6.9% CAGR between 2022 and 2032, totaling a market valuation of ~US$ 4.76 Billion by 2032.

Based on product, the single imaging gamma cameras segment dominated the global single-photon emission computed tomography market with a market share of about 75.5% in 2021 and it is likely to retain its dominance during the projected period.

Single-photon emission computed tomography is a potential nuclear medicine technique that produces 3-D images of functional processes in the human body while allowing non-invasive diagnostic imaging of metabolic processes using short-lived radioisotopes. Applications for single-photon emission computed tomography scanners are numerous and one key application is the detection of chronic illnesses.

Nuclear imaging apparatus includes single-photon emission computed tomography imaging systems. Single-photon emission computed tomography is used to assess the metabolic and functional data of cells and organs as it relates to disease processes. Enhancing various equipment's diagnostic capabilities in organic-specific or dual-modality systems has recently been crucial, and is anticipated to fuel market expansion during the projection period.

Attribute Key Statistics
Single Photo Emission Computed Tomography Market Base Value (2021) US$ 2.28 Billion
Estimated Market Value (2022) US$ 2.45 Billion
Projected Market Value (2032) US$ 4.76 Billion
Value-based CAGR (2022 to 2032) 6.9%
Market Share of Top 5 Countries 59.3%

The single-photon emission computed tomography (SPECT) systems market is driven by the rising prevalence of cancer, neurological diseases, and cardiovascular diseases.

Similarly, rising patient awareness, an increasing number of initiatives for research and development, and a rise in demand for diagnostic imaging devices such as MRI and X-ray devices are expected to boost the market during the forecast period. The overall single-photon emission computed tomography holds approximately 6.1% of the global medical imaging market which stood at US$ 37.2 Billion in 2021.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Single-Photon Emission Computed Tomography Market from 2012 to 2021 vs. Market Outlook for 2022 to 2032

The global single-photon emission computed tomography market expanded at a CAGR of 5.4% during the historic period from 2012 to 2021. However, with the growing demand for effective diagnostic techniques, the overall sales of single-photon emission computed tomography products are likely to grow at 6.9% CAGR through 2032.

Demand for single-photon emission computed tomography scanners in cancer diagnosis has increased significantly over the past few years and the trend is likely to continue during the forecast period. The technology offers a sophisticated diagnostic tool that helps in early disease diagnosis coupled with the capability to detect disease progression at each stage.

Cancer is one of the leading causes of death in many countries around the globe, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.

Industry experts have noted that the diagnostic accuracy of single-photon emission computed tomography scanners in certain clinical oncological examinations such as lung cancer, prostate cancer, colorectal cancer, melanoma, and several other cancers is higher than other diagnostic imaging techniques.

Manufacturers are concentrating on integrating several technological advancements into their single-photon emission computed tomography scanning machines, including higher storage capacity and increased efficiency about faster scanning times.

From a business perspective, increased data storage will enable physicians to archive more information from patients' prior scans, track tumor development over the course of a patient's disease prognosis, and perform more scans per day, increasing the financial viability of single-photon emission computed tomography scanners in the nuclear medicine industry.

Single-Photon Emission Computed Tomography Market

What are the Key Trends Driving the Global Single-Photon Emission Computed Tomography Market?

Growing Application of Single-Photon Emission Computed Tomography in Various Medical Fields and Advancements in radiopharmacy to Boost Market

Globally, single-photon emission computed tomography (SPECT) and X-ray transmission computed tomography (CT) scan hybrid imaging is becoming more popular. With the exact attenuation correction and fusion imaging that this cutting-edge technology offers, diagnostic sensitivity, and specificity are increased.

By defining prognostic and treatment monitoring capabilities and metabolic information provided by traditional nuclear imaging methods, the combination of SPECT and CT aids in improved disease staging. As a result, SPECT/CT has increasingly been used in clinical tests, particularly in the areas of musculoskeletal, cardiology, endocrinology, cancer, infection, and others. Due to their use in creating a customized treatment plan for individualized treatment, multimodality imaging techniques will further change diagnostic imaging procedures in the future.

The practice of nuclear medicine has changed dramatically over the past ten years as a result of amazing developments in radiopharmacy, instrumentation, and information technology, all of which have played significant roles in fostering the field's expansion.

The field of nuclear medicine has been revived by new technologies like PET/CT and SPECT/CT. It is also anticipated that the development of novel radiopharmaceuticals and other hybrid modalities, like SPECT/MRI, would spur the development of new diagnostic and therapeutic uses.

All the above scenarios offer a great opportunity for market growth during the forecast period from 2022 to 2032.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Growth of the Single-Photon Emission Computed Tomography Market?

The expansion of the single-photon emission computed tomography market over the projection period may be constrained by the lower availability and insufficient supply of molecular isotopes, which are necessary for diagnostic imaging devices.

For instance, there have been numerous supply shortages for technetium and molybdenum during the past few years, which are used in the bulk of SPECT operations in cardiology. Due to aging and safety concerns, the Canadian reactors that supply the molecular isotopes were permanently shut down in 2016, which limited the supply.

The field of nuclear medicine imaging has reached milestones with the advent of hybrid/fusion scanners which are paving the way to a new era in the field of imaging.

The introduction of new radiation detector systems in nuclear medicine imaging has led to a multifold increase in sensitivity and energy resolution. With the use of CZT (cadmium zinc telluride) detectors, SPECT/CT is likely to become organ-specific.

Similarly, the higher price of SPECT devices, such as SPECT-CT, SPECT-MRI, and the integration and combination of various diagnostics and imaging devices is usually a major cost restraint for the single-photon emission computed tomography market.

Only professionals who are trained within the healthcare domain for day-to-day operations and maintenance can work on single-photon emission computed tomography devices. Globally, the demand for SPECT devices is increasing. The shortage of trained specialists and professionals will hamper the growth of the global single-photon emission computed tomography market over the forecast period.

These factors cumulatively propose a negative effect on the developmental growth of the single-photon emission computed tomography market.

Country-wise Insights

What Makes the USA a Highly Lucrative Market for Single-Photon Emission Computed Tomography?

Presence of Favourable Reimbursement Policies Boosting Market in the USA

The USA holds approximately 38.0% share in the global single-photon emission computed tomography market in 2021 and is projected to grow at a robust pace during the forecast period.

Favorable reimbursement for nuclear medicine devices and treatment is increasing in North America which is expected to boost the growth of the United States of America single-photon emission computed tomography market.

The percentage of the total payor mix from private/self-pay revenue increased from 66.5% in 2018 to 67.4% in 2020. The Medicare percentage decreased from 21.8% to 20.5%.

What Makes China a Lucrative Single-Photon Emission Computed Tomography Market?

Rapid Expansion of Healthcare Infrastructure Generating demand in China

With a market share of over 5.3% in 2021 in the global market, China's single-photon emission computed tomography market is anticipated to grow at a healthy pace throughout the forecast period.

This expansion is attributed to the country's fast-developing medical infrastructure, an increase in scientific research on the diagnosis, treatment, and follow-up of chronic illnesses, as well as significant support from the public and commercial sectors for cancer research.

What is the Growth Projection for German Single-Photon Emission Computed Tomography Market?

Rising Geriatric Population Driving Market in Germany

As per FMI, Germany is set to hold a market share of nearly 5.0% in the global single-photon emission computed tomography market during the forecast period owing to an increase in the elderly population, increased prevalence of cancer, clinical usage of diagnostics techniques that use radiopharmaceuticals and increasing funding from the government.

40-59-year-olds make up the largest age group in Germany, at 23 million people. The most recent figures from 2021 confirm that the next-largest age group was 65 years and older, at 18.44 million.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which is the Most Commonly Used Product in Single-Photon Emission Computed Tomography Market?

Demand to Remain High for Single Imaging Cameras

The single imaging gamma cameras segment held a market share of about 75.5% in the global market in 2021 and it is expected to grow at a CAGR of 6.3% throughout the forecast period.

The most used imaging tool in nuclear medicine is the gamma camera, often known as a scintillation camera. It allows the capture of both dynamic and static images of the area of interest in the human body. Thus single-imaging gamma cameras are ahead of other products in the single-photon emission computed tomography market.

Which is the Most Lucrative Application for Single-Photon Emission Computed Tomography?

Growing Popularity of SPECT in Cardiology to Generate Maximum Revenues

Based on application, the cardiology segment held a revenue share of around 36.6% in the global single photon emission computed tomography market in 2021 and is expected to expand at a moderate growth rate over the forecast period.

Cardiologists utilize single-photon emission computed tomography to see how the blood flows through various areas of the heart. Doctors can see where and how well blood flows into and around the heart by injecting a radioactive tracer (such as technetium or sestamibi) that has been marked with gamma cameras. In this ailment, medical professionals determine whether a patient's heart has been negatively affected by conditions such as hypertension, coronary artery disease, atherosclerosis (artery hardening), valvular diseases like mitral valve prolapse, congenital bicuspid valves brought on by infection in early childhood, etc.

Which is the Leading End User of Single-Photon Emission Computed Tomography Products?

Most of the SPECT Product Sales Remain Concentrated in Hospitals

The hospital's segment held a 56.9% market share in the single-photon emission computed tomography market in 2021 and it is expected to grow at a CAGR of 7.6% during the forecast period, owing to the easy access and availability of SPECT products across hospitals for cardiology and oncology treatments.

The SPECT market will boost due to a large number of patients being admitted to the hospital for seeking treatment. The availability of advanced medical equipment with improved efficiency and technology along with trained staff and healthcare professionals add to the high growth of this segment.

Similarly, the presence of advanced medical equipment attracts a large number of patients to come to hospitals to seek treatment and get maximum satisfaction and relief. Thus hospitals are ahead of other end users in the single-photon emission computed tomography market.

Competitive Landscape

To establish a dominant position in the market, major players in the single-photon emission computed tomography market are aggressively concentrating on partnerships, product launches, and expansion. For instance,

  • In November 2020, GE Healthcare announced its acquisition of Prismatic Sensors AB, a Swedish startup specializing in photon-counting detectors, signifying the company’s continued investment in photon-counting CT technology.
  • In May 2022, Mediso Ltd announced the acquisition of Bartec Technologies Ltd, UK based company specializing in the supply, installation, and support of Nuclear Medicine and Molecular Imaging equipment and accessories.

Report Scope as per Single-photon Emission Computed Tomography Industry Analysis

Attribute Details
Estimated Market Size (2022) US$ 2.45 Billion
Projected Market Size (2032) US$ 4.76 Billion
Anticipated Growth Rate (2022 to 2032) 6.9%
Forecast Period 2012 to 2021
Historical Data Available for 2022 to 2032
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, Russia, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, Israel, North Africa, and South Africa
Key Market Segments Covered Product, Application, End User, and Region
Key Companies Profiled
  • Bruker Corp.
  • DDD-Diagnostic AS
  • Digmed Corp.
  • General Electric Co.
  • Mediso Ltd.
  • MiE GmbH
  • MILabs BV
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Inc.
  • GE Healthcare
  • CardiArc
  • Beijing Hamamatsu Photon Techniques INC.
  • SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
  • PNPMed
  • NuCare Inc.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Key Market Segments Covered in Single-photon Emission Computed Tomography Industry Research

By Product:

  • Single Imaging Gamma Cameras
  • SPECT/CT

By Application:

  • Cardiology
  • Oncology
  • Neurology
  • Others

By End User:

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

Frequently Asked Questions

What is the current size of the global single-photon emission computed tomography market?

The global single-photon emission computed tomography market is expected to reach worth US$ 2.45 Billion in 2022.

What is the sales forecast for the single-photon emission computed tomography through 2032?

The single-photon emission computed tomography is expected to reach US$ 4.76 Billion by the end of 2032, with sales revenue expected to register a growth rate of 6.9% CAGR.

What are the key trends shaping the single-photon emission computed tomography market?

Rapid technological advancements, rise in volume of free standing imaging centers, and expanded applications for single-photon emission computed tomography in oncology are some of the key trends in the single-photon emission computed tomography market.

Which are the top 5 countries driving demand for the single-photon emission computed tomography?

The USA, Japan, China, Germany, and the Uk are expected to drive demand for single-photon emission computed tomography.

What is the growth projection for North America single-photon emission computed tomography market?

North America, spearheaded by the USA will continue to remain one of the key markets for single-photon emission computed tomography.

At what rate will the demand for single-photon emission computed tomography grow in South Asia?

Demand for single-photon emission computed tomography in South Asia is expected to grow at 7.7% CAGR over the next ten years.

At what rate is the demand for single-photon emission computed tomography expected to rise in Europe?

Demand for single-photon emission computed tomography in Europe is expected to register a growth of 6.8% during the forecast period.

Which countries are the key producers of single-photon emission computed tomography?

The USA, Japan, and China are the key producers of single-photon emission computed tomography.

Who are the key players in the single-photon emission computed tomography market sphere?

Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, Spectrum Dynamics Medical Inc., GE Healthcare, CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA, MEDICAL APPARATUS CO., LTD., PNPMed, NuCare Inc. are some of the key players in the single-photon emission computed tomography market.

At what rate did the single-photon emission computed tomography market expand from 2012 until 2021?

The market for single-photon emission computed tomography expanded at a CAGR rate of 5.4% during the historical years of 2012 to 2021.

Table of Content

1. Executive Summary | Single-Photon Emission Computed Tomography Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Technology Roadmap

    4.2. Regulatory Scenario

    4.3. PESTLE Analysis

    4.4. Porter’s Analysis

    4.5. Value Chain Analysis

    4.6. Key Promotional Strategies by Manufacturers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Computed Tomography Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. GDP Growth

        5.2.2. Increasing Investment in R&D Activities

        5.2.3. Increased research into the manufacture of radiopharmaceuticals

        5.2.4. Increasing prevalence of cardiac diseases

        5.2.5. New Product Launch

        5.2.6. Advancement in technology

        5.2.7. Rise in the number of free-standing imaging centers

        5.2.8. Rising global demand for effective diagnostic techniques

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. Revenue By Product

        6.1.2. Revenue By Application

        6.1.3. Revenue By End User

        6.1.4. Revenue By Country

    6.2. 2021 Market Scenario

7. Global market Demand Volume (Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032

    7.1. Historical Market Volume (Units) Analysis, 2012 to 2021

    7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

    8.1. Regional Pricing Analysis, By Product

    8.2. Pricing Break Up

        8.2.1. Manufacturer Level

        8.2.2. Distributor Level

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032

    9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021

    9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2012 to 2021

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032

        10.3.1. Single Imaging Gamma Cameras

        10.3.2. SPECT/CT

    10.4. Market Attractiveness Analysis, By Product

11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million), By Application, 2012 to 2021

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032

        11.3.1. Cardiology

        11.3.2. Oncology

        11.3.3. Neurology

        11.3.4. Others

    11.4. Market Attractiveness Analysis, By Application

12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million), By End User, 2012 to 2021

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032

        12.3.1. Hospitals

        12.3.2. Diagnostic Imaging Centers

        12.3.3. Ambulatory Surgical Centers

    12.4. Market Attractiveness Analysis, By End User

13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Region, 2012 to 2021

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis, By Region

14. North America market Analysis 2012 to 2021 and Forecast 2022 to 2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021

    14.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        14.4.1. By Country

            14.4.1.1. United States of America

            14.4.1.2. Canada

        14.4.2. By Product

        14.4.3. By Application

        14.4.4. By End User

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By Application

        14.5.4. By End User

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country-Level Analysis & Forecast

        14.8.1. USA market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Product

                14.8.1.2.2. By Application

                14.8.1.2.3. By End User

        14.8.2. Canada Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Product

                14.8.2.2.2. By Application

                14.8.2.2.3. By End User

15. Latin America market Analysis 2012 to 2021 and Forecast 2022 to 2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021

    15.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        15.4.1. By Country

            15.4.1.1. Mexico

            15.4.1.2. Brazil

            15.4.1.3. Argentina

            15.4.1.4. Rest of Latin America

        15.4.2. By Product

        15.4.3. By Application

        15.4.4. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By Application

        15.5.4. By End User

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country-Level Analysis & Forecast

        15.8.1. Mexico Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Application

                15.8.1.2.3. By End User

        15.8.2. Brazil Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By Application

                15.8.2.2.3. By End User

        15.8.3. Argentina market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Product

                15.8.3.2.2. By Application

                15.8.3.2.3. By End User

16. Europe market Analysis 2012 to 2021 and Forecast 2022 to 2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021

    16.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. Italy

            16.4.1.3. France

            16.4.1.4. United Kingdom

            16.4.1.5. Spain

            16.4.1.6. BENELUX

            16.4.1.7. Russia

            16.4.1.8. Rest of Europe

        16.4.2. By Product

        16.4.3. By Application

        16.4.4. By End User

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By Application

        16.5.4. By End User

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country-Level Analysis & Forecast

        16.8.1. Germany Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Application

                16.8.1.2.3. By End User

        16.8.2. Italy Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Application

                16.8.2.2.3. By End User

        16.8.3. France Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By Application

                16.8.3.2.3. By End User

        16.8.4. UK market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast by Market Taxonomy

                16.8.4.2.1. By Product

                16.8.4.2.2. By Application

                16.8.4.2.3. By End User

        16.8.5. Spain Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast by Market Taxonomy

                16.8.5.2.1. By Product

                16.8.5.2.2. By Application

                16.8.5.2.3. By End User

        16.8.6. BENELUX market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast by Market Taxonomy

                16.8.6.2.1. By Product

                16.8.6.2.2. By Application

                16.8.6.2.3. By End User

        16.8.7. Russia Market Analysis

            16.8.7.1. Introduction

            16.8.7.2. Market Analysis and Forecast by Market Taxonomy

                16.8.7.2.1. By Product

                16.8.7.2.2. By Application

                16.8.7.2.3. By End User

17. South Asia market Analysis 2012 to 2021 and Forecast 2022 to 2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021

    17.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        17.4.1. By Country

            17.4.1.1. India

            17.4.1.2. Indonesia

            17.4.1.3. Malaysia

            17.4.1.4. Thailand

            17.4.1.5. Rest of South Asia

        17.4.2. By Product

        17.4.3. By Application

        17.4.4. By End User

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By Application

        17.5.4. By End User

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country-Level Analysis & Forecast

        17.8.1. India Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By Application

                17.8.1.2.3. By End User

        17.8.2. Indonesia arket Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By Application

                17.8.2.2.3. By End User

        17.8.3. Malaysia market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Product

                17.8.3.2.2. By Application

                17.8.3.2.3. By End User

        17.8.4. Thailand market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Product

                17.8.4.2.2. By Application

                17.8.4.2.3. By End User

18. East Asia market Analysis 2012 to 2021 and Forecast 2022 to 2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021

    18.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast By Market Taxonomy, 2022 to 2032

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

        18.4.2. By Product

        18.4.3. By Application

        18.4.4. By End User

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Product

        18.5.3. By Application

        18.5.4. By End User

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country-Level Analysis & Forecast

        18.8.1. China Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Application

                18.8.1.2.3. By End User

        18.8.2. Japan Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Application

                18.8.2.2.3. By End User

        18.8.3. South Korea market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Product

                18.8.3.2.2. By Application

                18.8.3.2.3. By End User

19. Oceania market 2012 to 2021 and Forecast 2022 to 2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021

    19.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        19.4.1. By Country

            19.4.1.1. Australia

            19.4.1.2. New Zealand

        19.4.2. By Product

        19.4.3. By Application

        19.4.4. By End User

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By Application

        19.5.4. By End User

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country-Level Analysis & Forecast

        19.8.1. Australia market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Application

                19.8.1.2.3. By End User

        19.8.2. New Zealand market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Application

                19.8.2.2.3. By End User

20. Middle East and Africa (MEA) market Analysis 2012 to 2021 and Forecast 2022 to 2032

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021

    20.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        20.4.1. By Country

            20.4.1.1. GCC Countries

            20.4.1.2. Turkey

            20.4.1.3. South Africa

            20.4.1.4. Rest of Middle East and Africa

        20.4.2. By Product

        20.4.3. By Application

        20.4.4. By End User

    20.5. Market Attractiveness Analysis

        20.5.1. By Country

        20.5.2. By Product

        20.5.3. By Application

        20.5.4. By End User

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country-Level Analysis & Forecast

        20.8.1. GCC Countries Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast by Market Taxonomy

                20.8.1.2.1. By Product

                20.8.1.2.2. By Application

                20.8.1.2.3. By End User

        20.8.2. Turkey market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast by Market Taxonomy

                20.8.2.2.1. By Product

                20.8.2.2.2. By Application

                20.8.2.2.3. By End User

        20.8.3. South Africa market Analysis

            20.8.3.1. Introduction

            20.8.3.2. Market Analysis and Forecast by Market Taxonomy

                20.8.3.2.1. By Product

                20.8.3.2.2. By Application

                20.8.3.2.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis, By Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

        21.3.1. Regional Footprint Analysis

        21.3.2. Product Footprint Analysis

        21.3.3. Channel Footprint Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Key Development Analysis

    22.4. Competition Deep Dive

        22.4.1. Koninklijke Philips NV

            22.4.1.1. Overview

            22.4.1.2. Product Portfolio

            22.4.1.3. Key Financial

            22.4.1.4. Sales Footprint

            22.4.1.5. Key Developments

            22.4.1.6. SWOT Analysis

            22.4.1.7. Strategy Overview

                22.4.1.7.1. Marketing Strategies

                22.4.1.7.2. Product Strategies

                22.4.1.7.3. Channel Strategies

        22.4.2. Bruker Corp.

            22.4.2.1. Overview

            22.4.2.2. Product Portfolio

            22.4.2.3. Key Financial

            22.4.2.4. Sales Footprint

            22.4.2.5. Key Developments

            22.4.2.6. SWOT Analysis

            22.4.2.7. Strategy Overview

                22.4.2.7.1. Marketing Strategies

                22.4.2.7.2. Product Strategies

                22.4.2.7.3. Channel Strategies

        22.4.3. DDD-Diagnostic AS

            22.4.3.1. Overview

            22.4.3.2. Product Portfolio

            22.4.3.3. Key Financial

            22.4.3.4. Sales Footprint

            22.4.3.5. Key Developments

            22.4.3.6. SWOT Analysis

            22.4.3.7. Strategy Overview

                22.4.3.7.1. Marketing Strategies

                22.4.3.7.2. Product Strategies

                22.4.3.7.3. Channel Strategies

        22.4.4. Digirad Corp.

            22.4.4.1. Overview

            22.4.4.2. Product Portfolio

            22.4.4.3. Key Financial

            22.4.4.4. Sales Footprint

            22.4.4.5. Key Developments

            22.4.4.6. SWOT Analysis

            22.4.4.7. Strategy Overview

                22.4.4.7.1. Marketing Strategies

                22.4.4.7.2. Product Strategies

                22.4.4.7.3. Channel Strategies

        22.4.5. General Electric Co.

            22.4.5.1. Overview

            22.4.5.2. Product Portfolio

            22.4.5.3. Key Financial

            22.4.5.4. Sales Footprint

            22.4.5.5. Key Developments

            22.4.5.6. SWOT Analysis

            22.4.5.7. Strategy Overview

                22.4.5.7.1. Marketing Strategies

                22.4.5.7.2. Product Strategies

                22.4.5.7.3. Channel Strategies

        22.4.6. Mediso Ltd.

            22.4.6.1. Overview

            22.4.6.2. Product Portfolio

            22.4.6.3. Key Financial

            22.4.6.4. Sales Footprint

            22.4.6.5. Key Developments

            22.4.6.6. SWOT Analysis

            22.4.6.7. Strategy Overview

                22.4.6.7.1. Marketing Strategies

                22.4.6.7.2. Product Strategies

                22.4.6.7.3. Channel Strategies

        22.4.7. MiE GmbH

            22.4.7.1. Overview

            22.4.7.2. Product Portfolio

            22.4.7.3. Key Financial

            22.4.7.4. Sales Footprint

            22.4.7.5. Key Developments

            22.4.7.6. SWOT Analysis

            22.4.7.7. Strategy Overview

                22.4.7.7.1. Marketing Strategies

                22.4.7.7.2. Product Strategies

                22.4.7.7.3. Channel Strategies

        22.4.8. MILabs BV

            22.4.8.1. Overview

            22.4.8.2. Product Portfolio

            22.4.8.3. Key Financial

            22.4.8.4. Sales Footprint

            22.4.8.5. Key Developments

            22.4.8.6. SWOT Analysis

            22.4.8.7. Strategy Overview

                22.4.8.7.1. Marketing Strategies

                22.4.8.7.2. Product Strategies

                22.4.8.7.3. Channel Strategies

        22.4.9. Siemens Healthineers AG

            22.4.9.1. Overview

            22.4.9.2. Product Portfolio

            22.4.9.3. Key Financial

            22.4.9.4. Sales Footprint

            22.4.9.5. Key Developments

            22.4.9.6. SWOT Analysis

            22.4.9.7. Strategy Overview

                22.4.9.7.1. Marketing Strategies

                22.4.9.7.2. Product Strategies

                22.4.9.7.3. Channel Strategies

        22.4.10. Spectrum Dynamics Medical Inc.

            22.4.10.1. Overview

            22.4.10.2. Product Portfolio

            22.4.10.3. Key Financial

            22.4.10.4. Sales Footprint

            22.4.10.5. Key Developments

            22.4.10.6. SWOT Analysis

            22.4.10.7. Strategy Overview

                22.4.10.7.1. Marketing Strategies

                22.4.10.7.2. Product Strategies

                22.4.10.7.3. Channel Strategies

        22.4.11. GE Healthcare

            22.4.11.1. Overview

            22.4.11.2. Product Portfolio

            22.4.11.3. Key Financial

            22.4.11.4. Sales Footprint

            22.4.11.5. Key Developments

            22.4.11.6. SWOT Analysis

            22.4.11.7. Strategy Overview

                22.4.11.7.1. Marketing Strategies

                22.4.11.7.2. Product Strategies

                22.4.11.7.3. Channel Strategies

        22.4.12. CardiArc

            22.4.12.1. Overview

            22.4.12.2. Product Portfolio

            22.4.12.3. Key Financial

            22.4.12.4. Sales Footprint

            22.4.12.5. Key Developments

            22.4.12.6. SWOT Analysis

            22.4.12.7. Strategy Overview

                22.4.12.7.1. Marketing Strategies

                22.4.12.7.2. Product Strategies

                22.4.12.7.3. Channel Strategies

        22.4.13. Beijing Hamamatsu Photon Techniques INC.

            22.4.13.1. Overview

            22.4.13.2. Product Portfolio

            22.4.13.3. Key Financial

            22.4.13.4. Sales Footprint

            22.4.13.5. Key Developments

            22.4.13.6. SWOT Analysis

            22.4.13.7. Strategy Overview

                22.4.13.7.1. Marketing Strategies

                22.4.13.7.2. Product Strategies

                22.4.13.7.3. Channel Strategies

        22.4.14. SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.

            22.4.14.1. Overview

            22.4.14.2. Product Portfolio

            22.4.14.3. Key Financial

            22.4.14.4. Sales Footprint

            22.4.14.5. Key Developments

            22.4.14.6. SWOT Analysis

            22.4.14.7. Strategy Overview

                22.4.14.7.1. Marketing Strategies

                22.4.14.7.2. Product Strategies

                22.4.14.7.3. Channel Strategies

        22.4.15. PNPMed

            22.4.15.1. Overview

            22.4.15.2. Product Portfolio

            22.4.15.3. Key Financial

            22.4.15.4. Sales Footprint

            22.4.15.5. Key Developments

            22.4.15.6. SWOT Analysis

            22.4.15.7. Strategy Overview

                22.4.15.7.1. Marketing Strategies

                22.4.15.7.2. Product Strategies

                22.4.15.7.3. Channel Strategies

        22.4.16. NuCare Inc.

            22.4.16.1. Overview

            22.4.16.2. Product Portfolio

            22.4.16.3. Key Financial

            22.4.16.4. Sales Footprint

            22.4.16.5. Key Developments

            22.4.16.6. SWOT Analysis

            22.4.16.7. Strategy Overview

                22.4.16.7.1. Marketing Strategies

                22.4.16.7.2. Product Strategies

                22.4.16.7.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology

Recommendations

Healthcare

Computed Tomography Market

Published : June 2024

Healthcare

Digital X-Ray Equipment Market

Published : March 2024

Healthcare

Positron Emission Tomography (PET) Scanners Market

Published : January 2023

Healthcare

Medical X-Ray Detectors Market

Published : June 2022

Explore Healthcare Insights

View Reports

Single-Photon Emission Computed Tomography Market